Actossideeffects.com is helping people file Actos Lawsuits

(LegalLaw247.com, November 26, 2011 ) Pensacola, FL -- Actos is a drug that has been prescribed to millions of people suffering from type two Diabetes. Actos was going to help people live normal lives and assist them supplying insulin and sugar to treat their condition. It was the first drug of choice after Avandia was taken off the shelves for causing an increased risk of heart conditions. Actos sales doubled in the last five years and over two million people have taken Actos. Actos has not only been linked to a risk of heart problems but also an increased risk of bladder cancer. Actos lawsuits are coming in from all over the globe.

The FDA required Actos to put a black box warning on their product and have issued warnings that if anyone has experienced bladder cancer symptoms or suffering from bladder cancer to discontinue use. The FDA has warned patients and physicians about the increased risk of Actos bladder cancer. France and Germany no longer allow Actos on their shelves.

The FDA has taken the data from Takeda Pharmaceuticals safety studies and they have concluded that the risk of bladder cancer was 40% higher if Actos was taken long term.

Japanese drug maker Takeda pharmaceuticals CO. LTD manufactured the drug and Actos lawsuits have been filed against them for negligence in complete testing and research into their product and lack of knowledge of its side effects.

Other Actos Side Effects are: heart disease, heart attacks, congestive heart failure, bladder cancer, liver and kidney disease, and bone fracture.

Patients who are prescribed Actos should be aware of all increased risks and the FDA warns physicians to discontinue the use of Actos in anyone who has had bladder cancer in the past.

About Actossideeffects.com:

Actossideeffects.com is helping patients that may have an Actos Lawsuit and connecting them with Actos Attorneys who will help them file their Actos Lawsuit.



Bill Bohack
1-800-bpclaim
Billbohack67@gmail.com

Source: EmailWire.Com
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>